Search


PDF Archive search engine
Last database update: 06 May at 08:40 - Around 76000 files indexed.


Show results per page

Results for «tumors»:


Total: 100 results - 0.06 seconds

JDIT-2014-1030-006 100%

www.openmedscience.com Review Article 68 Ga-Somatostatin Tumors Analogue PET/CT in Neuroendocrine Elisabetta Giovannini*, Maria Chiara Gaeta, Andrea Ciarmiello Nuclear Medicine Unit, Sant’Andrea Hospital, La Spezia, Italy *Author to whom correspondence should be addressed:

https://www.pdf-archive.com/2017/05/30/jdit-2014-1030-006/

29/05/2017 www.pdf-archive.com

2017DBS Antibody Flyer 102017 web 97%

It has demonstrated utility in the differential diagnosis between these primary tumors and corresponding metastatic renal cell carcinoma within the context of an antibody panel.

https://www.pdf-archive.com/2017/10/30/2017dbs-antibody-flyer-102017-web/

30/10/2017 www.pdf-archive.com

Abstract 97%

However, despite initial response, most patients experience relapse with resistant tumors within a year.

https://www.pdf-archive.com/2017/06/13/abstract/

13/06/2017 www.pdf-archive.com

cv-pantel 96%

Heterogeneous proliferative potential of occult metastatic cells in bone marrow of patients with solid epithelial tumors.

https://www.pdf-archive.com/2018/03/19/cv-pantel/

19/03/2018 www.pdf-archive.com

2534 - MD Anderson Cancer Center Madrid- Pathology Meeting - program 95%

Houston, USA 14:15 - 15:00 Aggressive tumors of the skin appendages:

https://www.pdf-archive.com/2018/06/18/untitled-pdf-document/

18/06/2018 www.pdf-archive.com

mammograms 95%

By Emily Oster Filed under Women's Health A Canadian study published in February reignited the years-long debate over breast cancer screening methods, arguing fairly strongly against mammography, or the use of X-rays to detect tumors.

https://www.pdf-archive.com/2017/02/23/mammograms-1/

23/02/2017 www.pdf-archive.com

Weinstein & Ciszek 2002 95%

Introduction Why do we get tumors and Why do we grow old?

https://www.pdf-archive.com/2017/06/11/weinstein-ciszek-2002/

11/06/2017 www.pdf-archive.com

JDIT-2014-1007-004 94%

Women with ER-positive breast tumors have a better prognosis than women with ER-negative tumors in terms of responsiveness to anti-estrogen treatment.

https://www.pdf-archive.com/2017/05/30/jdit-2014-1007-004/

29/05/2017 www.pdf-archive.com

Boston Biomarker Poster 03192014 94%

A MULTIANALYTE ALGORITHM PCR-BASED BLOOD TEST OUTPERFORMS SINGLE ANALYTE ELISA-BASED BLOOD TESTS FOR NEUROENDOCRINE TUMOR DETECTION A key issue in management of neuroendocrine tumors (NETs) is specific and sensitive biomarkers.

https://www.pdf-archive.com/2014/03/21/boston-biomarker-poster-03192014/

21/03/2014 www.pdf-archive.com

sample 81 82 83 94%

rarely, can cause carcinoid syndrome More common than primary tumors iv.

https://www.pdf-archive.com/2017/12/14/sample-81-82-83/

14/12/2017 www.pdf-archive.com

JDIT-2016-0712-022 94%

Because of the excellent outcome of DTC and the potential cancerous effect of iodine-131, in the last years there has been a huge number of articles addressing the issue of the incidence of second tumors in DTC patients.

https://www.pdf-archive.com/2017/05/30/jdit-2016-0712-022/

29/05/2017 www.pdf-archive.com

An Overview of Basal Cell Carcinoma 94%

Tumors appear most frequently on sun-exposed surfaces of the body (Sarma et al.

https://www.pdf-archive.com/2013/02/24/an-overview-of-basal-cell-carcinoma/

24/02/2013 www.pdf-archive.com

Abstract 93%

However, despite initial response, most patients experience relapse with resistant tumors within a year.

https://www.pdf-archive.com/2017/06/14/abstract/

14/06/2017 www.pdf-archive.com

2826 Pathology Meeting program 93%

Hematolymphoid tumors Moderator Dr.

https://www.pdf-archive.com/2018/08/08/2826pathology-meetingprogram/

08/08/2018 www.pdf-archive.com

CV 89%

https://www.pdf-archive.com/2017/09/14/cv/

14/09/2017 www.pdf-archive.com

asthetics 89%

aesthetics &

https://www.pdf-archive.com/2014/03/18/asthetics/

18/03/2014 www.pdf-archive.com

Ming You CV 08-25-2016 88%

Lung Cancers 2009 - 2010 Member, Scientific Review Committee, AACR Frontiers in Cancer Prevention Research Conference 2009 Member, American Institute of Biological Sciences “Molecular Signatures of Tumors Panel B” Peer Review Panel, U.S.

https://www.pdf-archive.com/2016/08/25/ming-you-cv-08-25-2016/

25/08/2016 www.pdf-archive.com

Nasarre Paper 87%

There is heterogeneity with respect to the autonomous invasive traits of epithelial-like breast cancer populations derived from different patient tumors (9, 10).

https://www.pdf-archive.com/2016/01/10/nasarre-paper/

10/01/2016 www.pdf-archive.com

Poster Final.. 87%

Classification, epidemiology, clinical presentation, localization, and staging of pancreatic neuroendocrine tumors.

https://www.pdf-archive.com/2017/06/08/poster-final/

07/06/2017 www.pdf-archive.com

9783662490105-c1 86%

The requirements of the first oncological disease—gastrointestinal tumors—were defined as late as 2014.

https://www.pdf-archive.com/2018/01/02/9783662490105-c1/

02/01/2018 www.pdf-archive.com

JDIT-2016-0906-024 85%

other tumors or inflammation processes.

https://www.pdf-archive.com/2017/05/30/jdit-2016-0906-024/

29/05/2017 www.pdf-archive.com

Final-Scientific-Program-UP-Cytocon-2019 84%

3.35 – 4.05 PM The MILAN system and molecular approach to cytologic diagnosis of salivary gland tumors Frontiers in molecular cytopathology 4.10 – 5.00 PM Potpourri of challenging cases in cytology 5.00 PM onwards Dr.

https://www.pdf-archive.com/2019/09/27/final-scientific-program-up-cytocon-2019/

27/09/2019 www.pdf-archive.com